Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMICOFET
NCT07818278Phase 4Not yet recruiting
- Sponsor
- Ghent University Hospital
- Start
- Oct 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Crinone and estradiol in infertility, sponsored by Ghent University Hospital. Primary endpoint: Endometrial hormonal concentrations at 8 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Crinoneestradiol
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07818278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07818278.